argenx SE
musk agonist with broad potential in neuromuscular disease | argenx SE
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
16 of 22
Similar slides by argenx SE
See diffirences between slides (animation)
Investor Presentation
November 2023
musk agonist with broad potential in neuromuscular disease clinical | argenx SE
Investor Presentation
August 2023
musk agonist with broad potential in neuromuscular disease | argenx SE
Investor Presentation
June 2023
musk agonist with broad potential in neuromuscular disease | argenx SE
Results
May 2023
musk agonist with broad potential in neuromuscular disease | argenx SE
Related slides by other companies
MindMed
Investor Presentation
June 2023
potential clinical care model | MindMed
Enochian Biosciences
Results
August 2023
potential application of to chronic infections including and or | Enochian Biosciences
Exscientia
Results
August 2023
and potential for a better clinical development strategy model driven adaptive learning in the clinic to insight | Exscientia
Pandion Therapeutics
IPO
July 2020
clinical stage company with broad pipeline | Pandion Therapeutics
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io